baber/WOPTO huggingface dataset:
Patent NZ-584234-A (NZ)
Title: A low noise distributed amplifier using destructive interference between input and output noise components
Inventor: VISSER BAREND
IPC: H03F1/18
Filed: 2008-10-01
Abstract: A distributed amplifier (10) having an amplification bandwidth extending from a first to a second higher frequency is disclosed. The distributed amplifier comprises an input transmission medium (12) having a first end (14) and a second end (16) and provides an input for the distributed amplifier at the first end and an output transmission medium (18) having a first end (20) and a second end (22) and provides an output for the distributed amplifier at the second end. An amplifier arrangement (30) comprises at least first and second amplifier parts (30.1 to 30.n) connected at an input (32) of the arrangement to the input transmission medium and at an output (34) of the arrangement to the output transmission medium, to provide at least first (36.1) and second (36.2) paths for an input signal from the input of the distributed amplifier to the output of the distributed amplifier; the first path being associated with a first phase change, the second path being associated with a second phase change and there being a difference between the first phase change and the second phase change; the difference being larger than 30 degrees for frequencies in a noise suppression band overlaps with the amplification band, which causes a phase difference between noise generated by the amplifier arrangement propagating along the first and second paths and destructive interference of the noise before the output of the distributed amplifier, thereby to suppress noise in the noise suppression band.
Patent NZ-596026-A (NZ)
Title: Concentrated, creamy to solid and dry compositions of an oil-in-water emulsion, method for the production thereof and use thereof for producing improved foods in terms of sensory aspects and nutrition physiology
Inventor: MUSCHIOLIK GERALD
IPC: A23L29/10
Filed: 2010-04-30
Abstract: Disclosed is a method for producing a composition of a phase-stable oil-in-water (O/W) emulsion having a dry mass content of between 5 to 60% by weight, containing, as related to the total weight of the emulsion, the following components: 0.2 to 10.0 % by weight of protein; 0.3 to 10.0 % by weight of polar polysaccharide; 0.1 to 60.0 % by weight of a fat/oil component; 0 to 30.0 % by weight of a polyol; wherein a phase that essentially consists of the fat/oil component (oil phase) (iii) and is optionally mixed with the polysaccharide (ii) or with a portion thereof is dispersed in an aqueous phase that contains the protein (i) and optionally the polysaccharide (ii) or a portion thereof, and wherein said emulsion is subsequently finely emulsified; and further comprising a step of concentrating and/or drying the emulsion.
Patent NZ-603745-A (NZ)
Title: Material treatment and apparatus
Inventor: MORRISON MICHAEL
IPC: C09K23/00
Filed: 2011-04-27
Abstract: A method and apparatus for very fine grinding is disclosed. The apparatus uses a rotor (42) with blades rapidly rotating in a compatible cylindrical housing. A friction inducing surface (50) on the cylindrical face (48) is provided in the gap between the blade faces and the housing inner surface to assist in the grinding effectiveness. The friction inducing surface is adhered to randomly shaped portions positioned in spaced apart locations around the periphery of the substantially cylindrical chamber.
Patent NZ-607797-A (NZ)
Title: Corticosteroids for the treatment of joint pain
Inventor: BODICK NEIL
IPC: A61K9/52
Filed: 2011-08-04
Abstract: Provided are corticosteroid microparticle formulations wherein a corticosteroid is incorporated in a lactic acid-glycolic acid copolymer matrix in the microparticle. These are of use in the treatment of joint pain. A preferred embodiment is a formulation comprising (a) controlled- or sustained-release microparticles comprising a Class B corticosteroid and a poly(lactic-co-glycolic) acid copolymer (PLGA) matrix, wherein the Class B corticosteroid comprises between 22% to 28% of the microparticles and wherein the PLGA has the following characteristics: (i) a molecular weight in the range of about 40 to 70 kDa; and (ii) a lactide:glycolide molar ratio of 80:20 to 60:40. A preferred Class B corticosteroid is triamcinolone acetonide.
Patent NZ-609880-A (NZ)
Title: Interchangeable shoe attachment
Inventor: FOGARTY CINDY
IPC: A43B9/00
Filed: 2011-10-28
Abstract: Disclosed is an article for footwear. The disclosure notes that interchangeable attachments (3) for footwear allow wearers to keep their footwear fashionable and reduce the need to purchase new footwear. The article includes a base member (1); sole member (2) and attachment member (3). The sole member (2) is recessed into the top of the base member (1). The attachment member (3) is fitted between the base member (1) and the sole member (2). The base member (1) further includes tracks along the length of the base member (1) allowing the attachment member (3) to be fitted fitted in between the base and the sole. The attachment member is interchangeable and easily slides into the tracks.
Patent NZ-703751-A (NZ)
Title: Cable sealing unit with multiple sealing modules
Inventor: COENEGRACHT PHILIPPE
IPC: H02G15/04
Filed: 2013-06-27
Abstract: A sealing unit (28) that fits within the sealing unit opening (26) of a housing (22). The sealing unit (28) including a sealant arrangement (32) that define a plurality of cable ports (30). The sealing arrangement is also configured for providing a peripheral seal between the housing (22) and the sealing unit (28). The sealing unit (28) includes an actuation arrangement (31) for pressurizing the sealant arrangement (32) within the sealing unit opening (26). The sealant arrangement (32) includes a plurality of sealing modules (33a-33e) each sized to form only a portion of the pressure actuated sealant arrangement (32).
Patent NZ-703787-A (NZ)
Title: Method and apparatus for feeding electric energy into an electric supply network
Inventor: BEEKMANN ALFRED
IPC: H02P9/10
Filed: 2013-07-03
Abstract: The present invention relates to a method of controlling a producer of electric energy which is connected to an electric supply grid. When changes in the operating conditions of a supply grid occur, loss of grid stability can have detrimental effects on the producer feeding in power to the supply grid. The present invention relates to a method of controlling feed in power into a supply grid based upon predetermining the stability characteristics of an electric supply grid under different operating conditions and subsequently feeding in power from the producer to the electric supply grid based upon the pre-determined stability characteristics of the electric supply grid.
Patent NZ-711144-A (NZ)
Title: Methods of disease activity profiling for personalized therapy management
Inventor: OHRMUND LINDA
IPC: G01N33/68
Filed: 2012-05-10
Abstract: A non-invasive method for selecting a therapy regimen to promote mucosal healing in an individual diagnosed with inflammatory bowel disease (IBD) comprises (a) measuring the levels of an array of mucosal healing markers in a sample obtained from the individual at time point t0 to generate a mucosal healing index at t0; (b) measuring the levels of an array of mucosal healing markers in a sample obtained from the individual at time point t1 to generate a mucosal healing index at t1; (c) comparing the change in the mucosal healing index from t0 to t1; and (d) selecting the therapy regimen for the individual to promote mucosal healing.
Patent NZ-714662-A (NZ)
Title: Extended-release formulation for reducing the frequency of urination and method of use thereof
Inventor: VOLFSON ILYA A
IPC: A61P13/10
Filed: 2013-03-14
Abstract: A pharmaceutical composition suitable for reducing frequency of urination, comprising: one or more analgesic agents selected from the group consisting of aspirin, ibuprofen, naproxen, naproxen sodium, indomethacin, nabumetone, and acetaminophen; one or more α-blockers or 5α-reductase inhibitors, and a pharmaceutically acceptable carrier wherein said one or more analgesic agents are formulated for extended release and wherein said one or more α-blockers are formulated for immediate release. The α-blocker may be tamsulosin and the 5α-reductase inhibitor may be finasteride.
Patent NZ-719654-A (NZ)
Title: Interleukin-2 fusion proteins and uses thereof
Inventor: MOESSNER EKKEHARD
IPC: C07K14/55
Filed: 2015-02-04
Abstract: The present invention generally relates to fusion proteins of immunoglobulins and interleukin-2 (IL-2). More particularly, the invention concerns fusion proteins of immunoglobulins and mutant IL-2 that exhibit improved properties for use as therapeutic agents, e.g. in the treatment of autoimmune diseases and immune-mediated inflammatory diseases. Specifically, the present invention relates to a fusion protein comprising an immunoglobulin incapable of specific binding to an antigen and two N88D mutant IL-2 molecules with reduced affinity to the intermediate affinity IL-2 receptor, for the increased activation of regulatory T cells. In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease, such as autoimmune diseases.
Patent NZ-722807-A (NZ)
Title: Cartridge with a heater assembly for an aerosol-generating system
Inventor: MIRONOV OLEG
IPC: H05B3/34
Filed: 2014-12-15
Abstract: The present specification relates to a cartridge with a heater assembly for an aerosol-generating system. Previously known systems include handheld electrically operated smoking systems consisting of a device portion comprising a battery and control electronics, and a cartridge portion comprising a supply of aerosol-forming substrate, and an electrically operated vapouriser. This type of system can be effective at producing aerosol, but it can also be challenging to manufacture and fragile. Alternatively, other systems using rectangular cartridges having sheetlike composites that include an integrally formed wick and heating element have been proposed. Such systems are complex to manufacture. The present specification provides a cartridge for use in an aerosol-generating system has a liquid storage portion and a heater assembly. The liquid storage portion has a housing for holding a liquid aerosol-forming substrate. The housing has an opening. The heater assembly has at least one heater element fixed to the housing and extending across the opening of the housing. The at least one heater element of the heater assembly has a width that is smaller than a width of the opening of the housing. The heater element is fluid permeable and comprises a plurality of electrically conductive filaments.
Patent NZ-733355-A (NZ)
Title: Reticle retention for optical apparatus
Inventor: HAMILTON DAVID
IPC: G02B23/00
Filed: 2015-12-30
Abstract: The disclosure relates to a reticle cell. The reticle cell comprises one or more pieces of reticle glass held inside a reticle ring by a retention washer; and a retention ring that retains the retention washer and engages the reticle ring and the reticle glass. The retention washer further includes tabs that engage corresponding channels on the inside of the reticle ring to prevent rotation of the reticle glass. This provides a greater accuracy, greater ease of manufacture of the reticle cell and, allows for superior optical quality.
Patent NZ-742900-A (NZ)
Title: Treatment of respiratory conditions by automatic control of flow and/or temperature and/or humidity independently to nares via separate flow paths
Inventor: FARRUGIA STEVEN PAUL
IPC: A61M16/16
Filed: 2009-05-28
Abstract: A device (102) provides respiratory treatment for SDB (including mild OSA) and other respiratory conditions. A flow generator warms and humidifies gas at controlled flow levels. For example, the device (102) delivers breathable gas to the upper airway at flow rates of about 10-35 liters/minute. Levels of flow rate, temperature and/or humidification of the device may be automatically adjusted in response to the detection of SDB events. The device may also automatically deliver adjustments of any of the levels in accordance with detected phases of respiratory cycles. In some embodiments, the device automatically delivers distinct levels to either of the nares based on independent control of flow to each nare. A warm-up procedure controls temperature and humidity at a desired target during a ramp-up of flow to the set therapy level. A cool-down procedure controls temperature above the dewpoint to avoid condensation internal to the device and patient interface.
Patent NZ-746544-A (NZ)
Title: Analogs of cyp-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation
Inventor: SCHUNCK WOLF-HAGEN
IPC: A61K31/341
Filed: 2017-04-03
Abstract: The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating or reducing the risk of developing or preventing: (i) neovascularization and/or (ii) inflammatory disorder, in particular, ophthalmic disorders associated with neovascularization and/or inflammation.
Patent NZ-747355-A (NZ)
Title: Composite profile for door, window or façade elements, and method for finishing manufacturing of a roll-in head of an insulating strip for door, window or façade elements
Inventor: HATZKY MARCEL
IPC: E06B3/273
Filed: 2017-04-25
Abstract: A composite profile (1) for doors, windows or façade elements, having profiles (2) and at least one insulating strip (3). At least one of the profiles (2) is made of a metal material with at least one roll-in groove (6) for roll-in connection with the insulating strip (3). The insulating strip (3) has a strip body (4) made of an insulating material extending in a longitudinal direction, and a roll-in head (5) at a longitudinal edge of the strip body (4). The roll-in head (5) has a cross-sectional shape in a plane perpendicular to the longitudinal direction adapted to be inserted into the at least one roll-in groove. The cross-sectional shape of the roll-in head has a first thickness, at or near a distal outer edge of the roll-in head, that is larger than a second thickness at a transition between the roll-in head and the strip body, the distal outer edge facing the at least one roll-in groove. A sheet (not shown) covers at least a part of a surface of the roll-in head (5) and comprising surface variations (not shown). The sheet is made of or comprises portions made of a metal material with a tensile strength of 300 N/mm2 or more, which is higher than the tensile strength of the metal profiles (2). The proposed invention provides door, window or façade elements with high shear strength.
Patent NZ-754320-A (NZ)
Title: Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
Inventor: RABOISSON PIERRE JEAN-MARIE BERNARD
IPC: C07D487/04
Filed: 2014-06-26
Abstract: This invention concerns pyrrolo[3,2-d]pyrimidine derivatives of compound (I), processes for their preparation, pharmaceutical compositions, and their use in treatment and /or therapy of diseases.
Patent PT-101452-A (PT)
Title: Dehydrogenation of amino-alcohol(s) - in aq. alkaline soln. in tank reactor with circulation by magnetically-coupled pump
IPC: C07C213/00
Filed: 1994-02-03
Abstract: Amino-alcohols are dehydrogenated onto amino-acids in aq. NaOH or KOH soln. at above 150 [deg]C in presence of Raney nickel as catalyst. The reaction is carried out in a tank reactor with circulation by means of a pump with magnetic coupling.
Patent PT-102002-A (PT)
Title: Non-oscillating vessel
IPC: B63B1/10
Filed: 1997-05-12
Abstract: The invention relates to the separation of the submerged volume from the non-submerged volume of a given vessel such that, the submerged volume being at a depth below the wave zone and the non-submerged volume being above it, the latter does not experience the force of the impact of the waves and is thus free from the resulting oscillation. The interpretation figure exemplifies the configuration of the vessel seen from the side, Figure C. <IMAGE>
Patent PT-102966-A (PT)
Title: Composition is of amino acids stimulatory of secretion of growth hormone and of dehydroepiandrosterone
Inventor: ZAMBUJAL RUI PEDRO ALVES
IPC: A61K31/195
Filed: 2003-06-03
Abstract: The composition is of amino acids stimulatory of the secretion of the growth hormone and of dehydroepiandrosterone. It serves to increase the secretion in persons in the process of ageing and compensates the possible secretion of the two hormones (or of at least one) in psychiatric affections. It increases somatic growth in adolescence. The increase in secretion of the growth hormone and/or of dehydroepiandrosterone in all the other clinical or sub-clinical situations in which an increased secretion of one or both hormones may be useful is also achieved. The composition may be as follows:- L-arginine 1mg L-lycine 1.2 mg L-glutamine 1.5 mg L-glycine 1.2 mg.
Patent RU-94001453-A (RU)
Inventor: EGOROV B S
IPC: H04B1/10
Filed: 1994-01-10
Abstract: FIELD: radio engineering. SUBSTANCE: radio signal received by antenna of radio receiving equipment is sent after preliminary amplification into multichannel autocorrelation processing circuit of receiver. Multiplication of received radio signal and of same radio signal delayed across delay line by random time τ′. is carried out in each channel of multichannel autocorrelation processing circuit. Value τ′ is supposed to be equal to interval of noise correlation multiplied by random number K distributed by law of uniform density in interval from 1 to 20: τ′=k•τ. Then integration of product of received and delayed signals is realized in each channel. Signals of all channels are summed up, are detected and fed into solving circuit. Availability of several processing channels makes it possible to increase signal-to-noise ratio across output of receiver by number of times equal to number of processing channels - n as signal power grows with summing in proportion to n(voltages are summed up) and noise power grows in proportion to n (noise powers which are uncorrelated due to change of time τ′ by random value are summed up). EFFECT: enhanced noise immunity of radio equipment receiving signal under conditions of unintentional noises.
Patent RU-94001578-A (RU)
Inventor: GOLIKOV V P
IPC: B63B35/73
Filed: 1994-01-18
Abstract: FIELD: shipbuilding. SUBSTANCE: catamaran driven by muscular force oarsman includes two floats secured together by means of platform and two external propulsion devices with doors, two internal and two external guides over which propulsion devices move, two gripping devices and two sticks coupled respectively with propulsion devices of internal and external pairs. Gripping devices are secured to oarsman's footwear. Oarsman is in skier posture performing propelling motion by his feet and hands. Braking and turning the catamaran will be effected due to locking the doors of external propulsion devices in open position by means of sticks and special braking stops. Speed of catamaran may be increased due to simultaneous operation of two hands and one foot of oarsman. EFFECT: enhanced efficiency. 10 cl, 16 dwg
Patent RU-94025597-A (RU)
Inventor: BEZUGLOV V V
IPC: A61K31/5575
Filed: 1994-07-07
Abstract: FIELD: medicine. SUBSTANCE: prostaglandin E1 dinitroglycerol ester is an active substance of agent proposed. Proposed agent can be realized as hydrophilic polymeric gel containing prostaglandin E1 dinitroglycerol ester both at micellar and polymeric forms. Agent is applied on the surface of damaged skin as a thin layer both once and some times per a day depending on the pattern of pathological process. Agent causes the local vessel dilatation, decrease of platelet aggregation (that leads to the improved microcirculation), enhances regenerative processes at damaged site without expressed by-side effects on the systemic dynamics. Inclusion of indicated compound in the soft medicinal form, for example, gel allows to attain its high local concentration that is necessary for therapeutic effect attainment and to prevent its rapid biodegradation. EFFECT: enhanced effectiveness of agent.
Patent RU-94028145-A (RU)
Inventor: RADCHENKO S A
IPC: F24H6/00
Filed: 1994-07-25
Abstract: FIELD: power engineering, sanitary engineering, heating and ventilation systems, and also hot-water and heating appliances, air-conditioning systems. SUBSTANCE: combination air and water heater has tank built up of external space, internal and intermediate spaces, casing, medium heating appliances, cold water feed and air vent systems, pipes for water supply to and discharge from intermediate space. Heating elements are mounted in external and intermediate spaces; the one installed in intermediate space is free to be transferred to internal space. Heat insulating shield is provided in bottom part of casing. Pipe for water supply to intermediate space is sectionalized; its lower section is detachable to facilitate connection of pipe feeding water to intermediate or internal space. EFFECT: improved water heating efficiency and heat-accumulating properties of device. 4 cl, 3 dwg
Patent RU-94033900-A (RU)
Inventor: SAMKHARADZE T G
IPC: G06F17/40
Filed: 1994-09-28
Abstract: FIELD: computer engineering, instruments, automatic recording systems. SUBSTANCE: device has controlling computer system with address-information and command data buses, group of n analog detectors, analog-to-digital converter, data processing unit, memory unit, buffer memory unit, commutator, and commutator control unit. In addition device has second group of n analog detectors, n-1 analog-to-digital converter of first group, n analog-to-digital converters of second group, second commutator, second commutator control unit, k-1 memory units, second buffer memory unit, two generator of information for transmission, two data transmission units, and input-output channel. Commutators joins n to k terminals. Device may be used in systems for monitoring and control of environment. Device provides possibility to operate without human control and to transmit bulk of reliable, low-redundant information which is joined in groups according to given characteristics of investigated environment. EFFECT: increased efficiency in use of computer system.
Patent RU-94036372-A (RU)
Inventor: VOLOSHIN L A
IPC: H04B1/10
Filed: 1994-09-21
Abstract: FIELD: radio engineering; communications systems using broad-band signals. SUBSTANCE: device has series-connected first subtractor, decoupling unit, third subtractor, first multiplier, first band filter, phase shifter, second multiplier, second subtractor, attenuator whose output is connected to other input of first subtractor. Inputs of subtractors are combined and function as input of device. Common point of second subtractor output and attenuator input is connected through series-connected adjustable- gain unit and switch to other input of third subtractor. Common point of first multiplier output and first band filter input is connected via series-connected second band filter, amplifier, automatic gain control detector to other input of adjustable-gain unit. Common point of first band filter output and phase shifter input is connected through computing circuit to other input of switch. Signal copy generator output is connected to other inputs of multipliers. Device output is common point of third subtractor output and first multiplier input. EFFECT: improved noise immunity.